Denial of Petition To Initiate Proceedings To Reschedule Marijuana

Document Headings Document headings vary by document type but may contain the following: the agency or agencies that issued and signed a document the number of the CFR title and the number of each part the document amends, proposes to amend, or is directly related to the agency docket number / agency internal file number the RIN which identifies each regulatory action listed in the Unified Agenda of Federal Regulatory and Deregulatory Actions See the Document Drafting Handbook for more details. Department of Justice Drug Enforcement Administration 21 CFR Chapter II [Docket No. DEA-427] AGENCY: Drug Enforcement Administration, Department of Justice. ACTION: Denial of petition to initiate proceedings to reschedule marijuana. SUMMARY: By letter dated July 19, 2016 the Drug Enforcement Administration (DEA) denied a petition to initiate rulemaking proceedings to reschedule marijuana. Because the DEA believes that this matter is of particular interest to members of the public, the agency is publishing below the letter sent to the petitioner which denied the petition, along with the supporting documentation that was attached to the letter. DATES: August 12, 2016. FOR FURTHER INFORMATION CONTACT: Michael J. Lewis, Office of Diversion Control, Drug Enforcement Administration; Mailing Address: 8701 Morrissette Drive, Springfield, Virginia 22152; Telephone: (202) 598-6812 SUPPLEMENTARY INFORMATION: July 19, 2016 Dear Mr. Krumm: On December 17, 2009, you petitioned the Drug Enforcement Administration (DEA) to initiate rulemaking proceedings under the rescheduling provisions of the Controlled Substances Act (CSA). Specifically, you petitioned DEA to have marijuana removed from schedule I of the CSA and rescheduled in any schedule other than schedule I of the CSA. You requested that DEA remove marijuana from schedule I based on your assertion that: 1. Marijuana has accepted medical use in the United States; 2. Studies have shown that smoked marijuana has proven safety and efficac…